To further evaluate the clinical significance of DRAK1 expression associated with chemoresistance, we performed IHC using human cervical cancer tissue microarrays (TMAs) obtained from Seoul National University College of Medicine in South Korea. Here, STK17A is linked to cervical carcinoma.